93 related articles for article (PubMed ID: 12441152)
1. Purification of Shiga-like toxin 1 by pigeon egg white glycoproteins immobilized on Sepharose gels.
Tomoda H; Arai M; Koyama N; Matsui H; O mura S; Obata R; Lee YC
Anal Biochem; 2002 Dec; 311(1):50-6. PubMed ID: 12441152
[TBL] [Abstract][Full Text] [Related]
2. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
3. Selective Detection of Shiga-like Toxin 1 from Complex Samples Using Pigeon Ovalbumin Functionalized Gold Nanoparticles as Affinity Probes.
Li CH; Bai YL; Selvaprakash K; Mong KT; Chen YC
J Agric Food Chem; 2017 May; 65(21):4359-4365. PubMed ID: 28493685
[TBL] [Abstract][Full Text] [Related]
4. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.
Nakajima H; Katagiri YU; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Mimori K; Saito M; Nakao H; Takeda T; Fujimoto J
Protein Expr Purif; 2001 Jul; 22(2):267-75. PubMed ID: 11437603
[TBL] [Abstract][Full Text] [Related]
5. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of major glycoproteins of pigeon egg white: ubiquitous presence of unique N-glycans containing Galalpha1-4Gal.
Suzuki N; Khoo KH; Chen HC; Johnson JR; Lee YC
J Biol Chem; 2001 Jun; 276(26):23221-9. PubMed ID: 11287422
[TBL] [Abstract][Full Text] [Related]
7. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the lethality of Shiga-like toxin-1 by functional gold nanoparticles.
Li CH; Bai YL; Chen YC
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):841-851. PubMed ID: 29447477
[TBL] [Abstract][Full Text] [Related]
9. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
10. Purification of recombinant Shiga-like toxin type I A1 fragment from Escherichia coli.
Zollman TM; Austin PR; Jablonski PE; Hovde CJ
Protein Expr Purif; 1994 Jun; 5(3):291-5. PubMed ID: 7950374
[TBL] [Abstract][Full Text] [Related]
11. N-glycan structures of pigeon IgG: a major serum glycoprotein containing Galalpha1-4 Gal termini.
Suzuki N; Khoo KH; Chen CM; Chen HC; Lee YC
J Biol Chem; 2003 Nov; 278(47):46293-306. PubMed ID: 12966096
[TBL] [Abstract][Full Text] [Related]
12. Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group.
Arimitsu H; Sasaki K; Kojima H; Yanaka T; Tsuji T
PLoS One; 2013; 8(12):e83577. PubMed ID: 24340102
[TBL] [Abstract][Full Text] [Related]
13. A method for the purification of Shiga-like toxin 1 subunit B using a commercially available galabiose-agarose resin.
Tarragó-Trani MT; Storrie B
Protein Expr Purif; 2004 Dec; 38(2):170-6. PubMed ID: 15555932
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences.
Armstrong GD; Fodor E; Vanmaele R
J Infect Dis; 1991 Dec; 164(6):1160-7. PubMed ID: 1659599
[TBL] [Abstract][Full Text] [Related]
15. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
Sung LM; Jackson MP; O'Brien AD; Holmes RK
J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
[TBL] [Abstract][Full Text] [Related]
16. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
17. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins.
Maria Cherian R; Gaunitz S; Nilsson A; Liu J; Karlsson NG; Holgersson J
Glycobiology; 2014 Jan; 24(1):26-38. PubMed ID: 24082034
[TBL] [Abstract][Full Text] [Related]
18. A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli.
He X; Quiñones B; McMahon S; Mandrell RE
Toxins (Basel); 2012 Jul; 4(7):487-504. PubMed ID: 22852065
[TBL] [Abstract][Full Text] [Related]
19. Immobilization of proteins on oxidized crosslinked Sepharose preparations by reductive amination.
Stults NL; Asta LM; Lee YC
Anal Biochem; 1989 Jul; 180(1):114-9. PubMed ID: 2554747
[TBL] [Abstract][Full Text] [Related]
20. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
